175 related articles for article (PubMed ID: 26104996)
1. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
Hohenwarter K; Prammer W; Aichinger W; Reychler G
J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
[TBL] [Abstract][Full Text] [Related]
3. Water filters can prevent Stenotrophomonas maltophilia contamination of nebuliser equipment used by people with cystic fibrosis.
Woodhouse R; Peckham DG; Conway SP; Denton M
J Hosp Infect; 2008 Apr; 68(4):371-2. PubMed ID: 18353498
[No Abstract] [Full Text] [Related]
4. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
[TBL] [Abstract][Full Text] [Related]
5. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
[TBL] [Abstract][Full Text] [Related]
6. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: poor adherence and the need to address it.
Duff AJ; Latchford GJ
J Cyst Fibros; 2010 Dec; 9(6):455-6. PubMed ID: 20840889
[No Abstract] [Full Text] [Related]
7. Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis.
Bos AC; Tiddens HA; Tong Minh K; Heeres I; Overweel-Uijterlinde JL; Kok AE; Andrinopoulou ER; Janssens HM
J Cyst Fibros; 2016 Sep; 15(5):645-51. PubMed ID: 27052127
[TBL] [Abstract][Full Text] [Related]
8. [Disinfection of devices for nebulization: stakes, difficulties, and improvement proposals].
Reychler G; Dupont C; Dubus JC; ;
Rev Mal Respir; 2007 Dec; 24(10):1351-61. PubMed ID: 18216754
[TBL] [Abstract][Full Text] [Related]
9. Lung function in adult patients with cystic fibrosis after using the eFlow rapid for one year.
Naehrig S; Lang S; Schiffl H; Huber RM; Fischer R
Eur J Med Res; 2011 Feb; 16(2):63-6. PubMed ID: 21463983
[TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.
Denton M; Rajgopal A; Mooney L; Qureshi A; Kerr KG; Keer V; Pollard K; Peckham DG; Conway SP
J Hosp Infect; 2003 Nov; 55(3):180-3. PubMed ID: 14572484
[TBL] [Abstract][Full Text] [Related]
11. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
[TBL] [Abstract][Full Text] [Related]
12. Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough?
Rosenfeld M; Joy P; Nguyen CD; Krzewinski J; Burns JL
J Hosp Infect; 2001 Nov; 49(3):229-30. PubMed ID: 11716644
[No Abstract] [Full Text] [Related]
13. Nebuliser therapy.
Esmond G
Prof Nurse; 1998 Oct; 14(1):39-43. PubMed ID: 9866617
[No Abstract] [Full Text] [Related]
14. Nebuliser systems for drug delivery in cystic fibrosis.
Daniels T; Mills N; Whitaker P
Paediatr Respir Rev; 2013 Jun; 14(2):98-9. PubMed ID: 23583049
[No Abstract] [Full Text] [Related]
15. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
[TBL] [Abstract][Full Text] [Related]
16. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
Heijerman H; Westerman E; Conway S; Touw D; Döring G;
J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
[TBL] [Abstract][Full Text] [Related]
17. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
[TBL] [Abstract][Full Text] [Related]
18. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
Jakobsson B; Hjelte L; Nyström B
J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
[TBL] [Abstract][Full Text] [Related]
19. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.
Newman SP; Woodman G; Clarke SW
Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919
[TBL] [Abstract][Full Text] [Related]
20. Frequency of contamination of single-patient-use nebulizers over time.
Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
